医学
放射外科
神经认知
重症监护医学
生活质量(医疗保健)
认知
疾病
临床试验
临床终点
放射治疗
叙述性评论
脑转移
心理干预
梅德林
随机对照试验
缓和医疗
内科学
精神科
护理部
作者
Krista Ariello,Hendrick Tan,Hany Soliman
出处
期刊:Annals of palliative medicine
[AME Publishing Company]
日期:2021-01-01
卷期号:10 (1): 923-935
摘要
Development of brain metastases are common in patients with advanced malignancies leading to significant morbidity and mortality. Although overall survival is an important endpoint in these patients, neurocognition and health related quality of life (HRQoL) more accurately highlights the impact of the disease and its treatment on patients. Whole brain radiotherapy (WBRT) has historically played a key role in the management of these patients, especially those with multiple brain metastases. Clinical trials have supported the use of stereotactic radiosurgery (SRS) alone in patients with limited brain metastases sparing neurocognitive function and HRQoL as compared to the combination of SRS plus WBRT. Furthermore, new systemic agents are increasingly being used in clinical practice and have shown promise in patients with brain metastases. The upcoming clinical trials are tasked with defining treatment guidelines that are more specific to patient and tumour factors incorporating radiation, surgery, and systemic therapy. The validity of findings in these trials rest on the rigor of the study methodology and the utilisation of validated assessment tools for neurocognition and HRQoL. This review aims to appraise and summarise the neurocognitive and HRQoL tools used in modern brain metastases trials.
科研通智能强力驱动
Strongly Powered by AbleSci AI